EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Dual Mechanistic Actions of Natural Compounds CAPE and EGCG Targeting VEGF and PI3K/Akt/mTOR Pathways in Lung Cancer

Yağmur Dilber, Gülçin Ekizçeli, Elgin Türköz Uluer, Kemal Özbilgin, Sevinç İnan

European Journal of Therapeutics · 19.08.2026 · 32 (4) · 388-399

DOI: 10.58600/eurjther2982 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Therapeutics, online erschienen am 19.08.2026. Verfasst von Yağmur Dilber und 4 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Lung cancer is characterized by uncontrolled proliferation, loss of apoptosis, angiogenesis, and metastatic potential. Caffeic acid phenethyl ester (CAPE), the major bioactive molecule of propolis, and epigallocatechin gallate (EGCG), a essential polyphenol of green tea, have documented antioxidant, anti-proliferative, and anti-angiogenic effects. This study aimed to investigate the effects of EGCG and CAPE on VEGF and the PI3K/Akt/mTOR signaling pathway, key regulators of lung cancer progression, using in silico and in vitro models.

Methods

This study Lung cancer cells (DSMZ/ACC-234) was conducted to demonstrate the inhibition of cell proliferation by the MTT method, molecular binding via autodock vina and protein expression by immunohistochemistry analysis, targeting the VEGF and PI3K/Akt/mTOR pathways with CAPE and EGCG treatment.

Results

EGCG and CAPE treatments significantly reduced cell proliferation in lung cancer cells. Untreated cells exhibited strong to very strong immunoreactivity for VEGF and PI3K/Akt/mTOR pathway markers, whereas EGCG reduced these signals to mild–moderate levels and to CAPE moderate–strong levels. Since both treatments resulted in a statistically significant increase in mTORC1 immunoreactivity, molecular docking targeting was performed via it.

Conclusion

EGCG and CAPE exhibit significant anti-proliferative and anti-angiogenic effects by adjusting the VEGF and PI3K/Akt/mTOR signaling pathways in lung cancer cells. mTORC1 activation molecular binding affinity is higher in the CAPE-treated group compared to the EGCG group. These findings highlight the therapeutic importance of targeting these pathways in developing novel treatment strategies for lung cancer.

Zitieren

APA

Dilber, Y., Ekizçeli, G., Uluer, E. T., Özbilgin, K., & İnan, S. (2026). The Dual Mechanistic Actions of Natural Compounds CAPE and EGCG Targeting VEGF and PI3K/Akt/mTOR Pathways in Lung Cancer. European Journal of Therapeutics, 32(4), 388-399. https://doi.org/10.58600/eurjther2982

Vancouver

Dilber Y, Ekizçeli G, Uluer ET, Özbilgin K, İnan S. The Dual Mechanistic Actions of Natural Compounds CAPE and EGCG Targeting VEGF and PI3K/Akt/mTOR Pathways in Lung Cancer. European Journal of Therapeutics. 2026;32(4):388-399. doi:10.58600/eurjther2982

BibTeX
@article{Dilber2026,
  author = {Dilber, Yağmur and Ekizçeli, Gülçin and Uluer, Elgin Türköz and Özbilgin, Kemal and İnan, Sevinç},
  title = {The Dual Mechanistic Actions of Natural Compounds CAPE and EGCG Targeting VEGF and PI3K/Akt/mTOR Pathways in Lung Cancer},
  journal = {European Journal of Therapeutics},
  year = {2026},
  volume = {32},
  number = {4},
  pages = {388--399},
  doi = {10.58600/eurjther2982}
}
Kostenlos starten →